A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae

Area of Science:

• Immunology
• Microbiology
• Infectious Diseases

Background:

• Leprosy control requires identifying Mycobacterium leprae-specific antigens that reflect the immune response spectrum.
• Understanding host responses to M. leprae antigens is crucial for diagnostic and therapeutic advancements.

Purpose of the Study:

• To investigate the host immune response to a 35-kDa protein of Mycobacterium leprae.
• To evaluate the potential of this M. leprae antigen as a diagnostic marker or vaccine component.

Main Methods:

• Production and purification of recombinant 35-kDa M. leprae protein from Mycobacterium smegmatis and Escherichia coli.
• Assessment of antigen properties, including multimeric complex formation and antibody binding.
• Evaluation of T-cell proliferative responses and immunoglobulin G antibody production in leprosy patients, contacts, and tuberculosis patients.
• Delayed-type hypersensitivity testing in guinea pigs sensitized with different mycobacterial species.

Main Results:

• The M. smegmatis-derived 35-kDa protein exhibited properties similar to the native antigen and was recognized by sera from leprosy patients.
• A significant T-cell proliferative response to the M. smegmatis-derived protein was observed in paucibacillary leprosy patients and healthy contacts, but not in multibacillary patients.
• The 35-kDa protein elicited specific T-cell and antibody responses in most leprosy patients and contacts, with minimal recognition by tuberculosis patients.
• Guinea pig studies confirmed the antigen's specificity for M. leprae sensitization.

Conclusions:

• The M. leprae 35-kDa protein derived from M. smegmatis is a major and specific target of the human immune response to M. leprae.
• This antigen holds potential for use in diagnostic tests to detect leprosy exposure and in the development of a leprosy vaccine.